All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Dynamk Capital, of Englewood Cliffs, N.J., a new life sciences venture capital fund, said it invested $500,000 in New York-based Envisagenics Inc., leading the firm's $2.25 million seed round.